Items Tagged ‘oncology’

April 2, 2012

Partnering With Disease: 9 Doctors Studying an Illness Close to Home

By Mystery User

If you’re very lucky, you’ll never know disease. A blend of good genes and good fortune might let you walk through life ducking the conditions that knock down others. But some people get intimate with disease, either by chance or choice…A lifelong non-smoker, Dr. Lewis’ (Mayo Clinic physician) father had mysteriously died of lung cancer […]

View full entry

Tags: oncology


January 26, 2012

Zoledronic Acid Controversy in Breast Cancer Continues

By Mystery User

A growing body of evidence backs the contention that bisphosphonates can improve survival in breast cancer patients with low estrogen levels. The results of three studies of bisphosphonates in this setting presented at the recent San Antonio Breast Cancer Symposium (SABCS) support the low estrogen hypothesis, whereas interim results of a fourth trial presented there […]

View full entry

Tags: Breast Cancer, Dr. James Ingle, estrogen levels, oncology, San Antonio Breast Cancer Symposium


October 23, 2009

ASCO Rx for High Drug Costs: Doctors and Patients Need To Talk

By Kelley Luckstein Kelley Luckstein

A special task force of the American Society of Clinical Oncology (ASCO) recently issued a Guidance Statement on the Cost of Care, which advises oncologists to speak with their patients about the cost of treatment. While urging ASCO to also address underlying economic factors that drive costs, the guidance focused on issues at the practice […]

View full entry

Tags: ASCO, oncology, treatment


October 22, 2009

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma

By Kelley Luckstein Kelley Luckstein

High-dose dexamethasone is a mainstay of therapy for multiple myeloma. We studied whether low-dose dexamethasone in combination with lenalidomide is non-inferior to and has lower toxicity than high-dose dexamethasone plus lenalidomide…   Lenalidomide plus low-dose dexamethasone is associated with better short-term overall survival and with lower toxicity than lenalidomide plus high-dose dexamethasone in patients with […]

View full entry

Tags: dexamethasone, oncology


Contact Us · Privacy Policy